Correlation Between Merck and EQUIFAX

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Merck and EQUIFAX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Merck and EQUIFAX into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Merck Company and EQUIFAX INC 7, you can compare the effects of market volatilities on Merck and EQUIFAX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Merck with a short position of EQUIFAX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Merck and EQUIFAX.

Diversification Opportunities for Merck and EQUIFAX

0.04
  Correlation Coefficient

Significant diversification

The 3 months correlation between Merck and EQUIFAX is 0.04. Overlapping area represents the amount of risk that can be diversified away by holding Merck Company and EQUIFAX INC 7 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EQUIFAX INC 7 and Merck is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Merck Company are associated (or correlated) with EQUIFAX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EQUIFAX INC 7 has no effect on the direction of Merck i.e., Merck and EQUIFAX go up and down completely randomly.

Pair Corralation between Merck and EQUIFAX

Considering the 90-day investment horizon Merck Company is expected to under-perform the EQUIFAX. But the stock apears to be less risky and, when comparing its historical volatility, Merck Company is 1.33 times less risky than EQUIFAX. The stock trades about -0.16 of its potential returns per unit of risk. The EQUIFAX INC 7 is currently generating about -0.11 of returns per unit of risk over similar time horizon. If you would invest  11,211  in EQUIFAX INC 7 on August 24, 2024 and sell it today you would lose (311.00) from holding EQUIFAX INC 7 or give up 2.77% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy60.87%
ValuesDaily Returns

Merck Company  vs.  EQUIFAX INC 7

 Performance 
       Timeline  
Merck Company 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Merck Company has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
EQUIFAX INC 7 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days EQUIFAX INC 7 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unfluctuating performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for EQUIFAX INC 7 investors.

Merck and EQUIFAX Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Merck and EQUIFAX

The main advantage of trading using opposite Merck and EQUIFAX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Merck position performs unexpectedly, EQUIFAX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EQUIFAX will offset losses from the drop in EQUIFAX's long position.
The idea behind Merck Company and EQUIFAX INC 7 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
FinTech Suite
Use AI to screen and filter profitable investment opportunities
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like